Kidney Transplant Rejection Biomarker Market

Transplant centers represent 44.0% of end user demand, acute rejection detection accounts for 34.0% of application sales and next-generation sequencing (NGS) holds 33.2% within the technology segment in 2026. The kidney transplant rejection biomarker market was valued at USD 1,224.4 million in 2025 and is forecast to post an 11.3% CAGR between 2026 and 2036.